id	sid	tid	token	lemma	pos
cord-032438-cpoalxyd	1	1	key	key	NN
cord-032438-cpoalxyd	1	2	:	:	:
cord-032438-cpoalxyd	1	3	cord-032438-cpoalxyd	cord-032438-cpoalxyd	ADD
cord-032438-cpoalxyd	2	1	authors	author	NNS
cord-032438-cpoalxyd	2	2	:	:	:
cord-032438-cpoalxyd	2	3	Nachega	Nachega	NNP
cord-032438-cpoalxyd	2	4	,	,	,
cord-032438-cpoalxyd	2	5	Jean	Jean	NNP
cord-032438-cpoalxyd	2	6	B	B	NNP
cord-032438-cpoalxyd	2	7	;	;	:
cord-032438-cpoalxyd	2	8	Fatti	Fatti	NNP
cord-032438-cpoalxyd	2	9	,	,	,
cord-032438-cpoalxyd	2	10	Geoffrey	Geoffrey	NNP
cord-032438-cpoalxyd	2	11	;	;	:
cord-032438-cpoalxyd	2	12	Zumla	Zumla	NNP
cord-032438-cpoalxyd	2	13	,	,	,
cord-032438-cpoalxyd	2	14	Alimuddin	Alimuddin	NNP
cord-032438-cpoalxyd	2	15	;	;	:
cord-032438-cpoalxyd	2	16	Geng	Geng	NNP
cord-032438-cpoalxyd	2	17	,	,	,
cord-032438-cpoalxyd	2	18	Elvin	Elvin	NNP
cord-032438-cpoalxyd	2	19	H	H	NNP
cord-032438-cpoalxyd	3	1	title	title	NN
cord-032438-cpoalxyd	3	2	:	:	:
cord-032438-cpoalxyd	4	1	The	the	DT
cord-032438-cpoalxyd	4	2	where	where	WRB
cord-032438-cpoalxyd	4	3	,	,	,
cord-032438-cpoalxyd	4	4	when	when	WRB
cord-032438-cpoalxyd	4	5	,	,	,
cord-032438-cpoalxyd	4	6	and	and	CC
cord-032438-cpoalxyd	4	7	how	how	WRB
cord-032438-cpoalxyd	4	8	of	of	IN
cord-032438-cpoalxyd	4	9	community	community	NN
cord-032438-cpoalxyd	4	10	-	-	HYPH
cord-032438-cpoalxyd	4	11	based	base	VBN
cord-032438-cpoalxyd	4	12	versus	versus	IN
cord-032438-cpoalxyd	4	13	clinic	clinic	NN
cord-032438-cpoalxyd	4	14	-	-	HYPH
cord-032438-cpoalxyd	4	15	based	base	VBN
cord-032438-cpoalxyd	4	16	ART	art	NN
cord-032438-cpoalxyd	4	17	delivery	delivery	NN
cord-032438-cpoalxyd	4	18	in	in	IN
cord-032438-cpoalxyd	4	19	South	South	NNP
cord-032438-cpoalxyd	4	20	Africa	Africa	NNP
cord-032438-cpoalxyd	4	21	and	and	CC
cord-032438-cpoalxyd	4	22	Uganda	Uganda	NNP
cord-032438-cpoalxyd	4	23	date	date	NN
cord-032438-cpoalxyd	4	24	:	:	:
cord-032438-cpoalxyd	4	25	2020	2020	CD
cord-032438-cpoalxyd	4	26	-	-	HYPH
cord-032438-cpoalxyd	4	27	09	09	CD
cord-032438-cpoalxyd	4	28	-	-	SYM
cord-032438-cpoalxyd	4	29	21	21	CD
cord-032438-cpoalxyd	4	30	journal	journal	NN
cord-032438-cpoalxyd	4	31	:	:	:
cord-032438-cpoalxyd	5	1	Lancet	Lancet	NNP
cord-032438-cpoalxyd	5	2	Glob	Glob	NNP
cord-032438-cpoalxyd	5	3	Health	Health	NNP
cord-032438-cpoalxyd	5	4	DOI	doi	NN
cord-032438-cpoalxyd	5	5	:	:	:
cord-032438-cpoalxyd	6	1	10.1016	10.1016	CD
cord-032438-cpoalxyd	6	2	/	/	SYM
cord-032438-cpoalxyd	6	3	s2214	s2214	NN
cord-032438-cpoalxyd	6	4	-	-	HYPH
cord-032438-cpoalxyd	6	5	109x(20)30385	109x(20)30385	CD
cord-032438-cpoalxyd	6	6	-	-	SYM
cord-032438-cpoalxyd	6	7	5	5	CD
cord-032438-cpoalxyd	6	8	sha	sha	NN
cord-032438-cpoalxyd	6	9	:	:	:
cord-032438-cpoalxyd	7	1	e76d4dea1e9ef14e40e35ccf8695b1b465ce92f4	e76d4dea1e9ef14e40e35ccf8695b1b465ce92f4	NNP
cord-032438-cpoalxyd	7	2	doc_id	doc_id	NNP
cord-032438-cpoalxyd	7	3	:	:	:
cord-032438-cpoalxyd	7	4	32438	32438	CD
cord-032438-cpoalxyd	7	5	cord_uid	cord_uid	NN
cord-032438-cpoalxyd	7	6	:	:	:
cord-032438-cpoalxyd	8	1	cpoalxyd	cpoalxyd	NNP
cord-032438-cpoalxyd	9	1	nan	nan	NNP
cord-032438-cpoalxyd	9	2	Antiretroviral	Antiretroviral	NNP
cord-032438-cpoalxyd	9	3	therapy	therapy	NN
cord-032438-cpoalxyd	9	4	(	(	-LRB-
cord-032438-cpoalxyd	9	5	ART	art	NN
cord-032438-cpoalxyd	9	6	)	)	-RRB-
cord-032438-cpoalxyd	9	7	can	can	MD
cord-032438-cpoalxyd	9	8	suppress	suppress	VB
cord-032438-cpoalxyd	9	9	HIV	HIV	NNP
cord-032438-cpoalxyd	9	10	plasma	plasma	NN
cord-032438-cpoalxyd	9	11	RNA	RNA	NNP
cord-032438-cpoalxyd	9	12	concentrations	concentration	NNS
cord-032438-cpoalxyd	9	13	and	and	CC
cord-032438-cpoalxyd	9	14	harmful	harmful	JJ
cord-032438-cpoalxyd	9	15	effects	effect	NNS
cord-032438-cpoalxyd	9	16	of	of	IN
cord-032438-cpoalxyd	9	17	the	the	DT
cord-032438-cpoalxyd	9	18	virus	virus	NN
cord-032438-cpoalxyd	9	19	.	.	.
cord-032438-cpoalxyd	10	1	However	however	RB
cord-032438-cpoalxyd	10	2	,	,	,
cord-032438-cpoalxyd	10	3	at	at	IN
cord-032438-cpoalxyd	10	4	present	present	JJ
cord-032438-cpoalxyd	10	5	,	,	,
cord-032438-cpoalxyd	10	6	only	only	RB
cord-032438-cpoalxyd	10	7	about	about	RB
cord-032438-cpoalxyd	10	8	60	60	CD
cord-032438-cpoalxyd	10	9	%	%	NN
cord-032438-cpoalxyd	10	10	of	of	IN
cord-032438-cpoalxyd	10	11	people	people	NNS
cord-032438-cpoalxyd	10	12	living	live	VBG
cord-032438-cpoalxyd	10	13	with	with	IN
cord-032438-cpoalxyd	10	14	HIV	HIV	NNP
cord-032438-cpoalxyd	10	15	are	be	VBP
cord-032438-cpoalxyd	10	16	virally	virally	RB
cord-032438-cpoalxyd	10	17	suppressed	suppress	VBN
cord-032438-cpoalxyd	10	18	.	.	.
cord-032438-cpoalxyd	11	1	1	1	LS
cord-032438-cpoalxyd	12	1	Therefore	therefore	RB
cord-032438-cpoalxyd	12	2	,	,	,
cord-032438-cpoalxyd	12	3	global	global	JJ
cord-032438-cpoalxyd	12	4	public	public	JJ
cord-032438-cpoalxyd	12	5	health	health	NN
cord-032438-cpoalxyd	12	6	programmes	programme	NNS
cord-032438-cpoalxyd	12	7	urgently	urgently	RB
cord-032438-cpoalxyd	12	8	need	need	VBP
cord-032438-cpoalxyd	12	9	innovative	innovative	JJ
cord-032438-cpoalxyd	12	10	approaches	approach	NNS
cord-032438-cpoalxyd	12	11	to	to	TO
cord-032438-cpoalxyd	12	12	improve	improve	VB
cord-032438-cpoalxyd	12	13	the	the	DT
cord-032438-cpoalxyd	12	14	rapidity	rapidity	NN
cord-032438-cpoalxyd	12	15	and	and	CC
cord-032438-cpoalxyd	12	16	durability	durability	NN
cord-032438-cpoalxyd	12	17	of	of	IN
cord-032438-cpoalxyd	12	18	engaging	engage	VBG
cord-032438-cpoalxyd	12	19	patients	patient	NNS
cord-032438-cpoalxyd	12	20	in	in	IN
cord-032438-cpoalxyd	12	21	treatment	treatment	NN
cord-032438-cpoalxyd	12	22	.	.	.
cord-032438-cpoalxyd	13	1	In	in	IN
cord-032438-cpoalxyd	13	2	this	this	DT
cord-032438-cpoalxyd	13	3	issue	issue	NN
cord-032438-cpoalxyd	13	4	of	of	IN
cord-032438-cpoalxyd	13	5	The	the	DT
cord-032438-cpoalxyd	13	6	Lancet	Lancet	NNP
cord-032438-cpoalxyd	13	7	Global	Global	NNP
cord-032438-cpoalxyd	13	8	Health	Health	NNP
cord-032438-cpoalxyd	13	9	,	,	,
cord-032438-cpoalxyd	13	10	Ruanne	Ruanne	NNP
cord-032438-cpoalxyd	13	11	Barnabas	Barnabas	NNP
cord-032438-cpoalxyd	13	12	and	and	CC
cord-032438-cpoalxyd	13	13	colleagues	colleague	NNS
cord-032438-cpoalxyd	13	14	report	report	VBP
cord-032438-cpoalxyd	13	15	results	result	NNS
cord-032438-cpoalxyd	13	16	of	of	IN
cord-032438-cpoalxyd	13	17	the	the	DT
cord-032438-cpoalxyd	13	18	Delivery	Delivery	NNP
cord-032438-cpoalxyd	13	19	Optimization	Optimization	NNP
cord-032438-cpoalxyd	13	20	of	of	IN
cord-032438-cpoalxyd	13	21	Antiretroviral	Antiretroviral	NNP
cord-032438-cpoalxyd	13	22	Therapy	Therapy	NNP
cord-032438-cpoalxyd	13	23	(	(	-LRB-
cord-032438-cpoalxyd	13	24	DO	DO	NNP
cord-032438-cpoalxyd	13	25	-	-	HYPH
cord-032438-cpoalxyd	13	26	ART	art	NN
cord-032438-cpoalxyd	13	27	)	)	-RRB-
cord-032438-cpoalxyd	13	28	study	study	NN
cord-032438-cpoalxyd	13	29	,	,	,
cord-032438-cpoalxyd	13	30	a	a	DT
cord-032438-cpoalxyd	13	31	multicentre	multicentre	NNP
cord-032438-cpoalxyd	13	32	,	,	,
cord-032438-cpoalxyd	13	33	randomised	randomised	JJ
cord-032438-cpoalxyd	13	34	trial	trial	NN
cord-032438-cpoalxyd	13	35	comparing	compare	VBG
cord-032438-cpoalxyd	13	36	community	community	NN
cord-032438-cpoalxyd	13	37	-	-	HYPH
cord-032438-cpoalxyd	13	38	based	base	VBN
cord-032438-cpoalxyd	13	39	ART	art	NN
cord-032438-cpoalxyd	13	40	initiation	initiation	NN
cord-032438-cpoalxyd	13	41	,	,	,
cord-032438-cpoalxyd	13	42	monitoring	monitoring	NN
cord-032438-cpoalxyd	13	43	,	,	,
cord-032438-cpoalxyd	13	44	and	and	CC
cord-032438-cpoalxyd	13	45	resupply	resupply	VB
cord-032438-cpoalxyd	13	46	with	with	IN
cord-032438-cpoalxyd	13	47	use	use	NN
cord-032438-cpoalxyd	13	48	of	of	IN
cord-032438-cpoalxyd	13	49	a	a	DT
cord-032438-cpoalxyd	13	50	hybrid	hybrid	JJ
cord-032438-cpoalxyd	13	51	approach	approach	NN
cord-032438-cpoalxyd	13	52	(	(	-LRB-
cord-032438-cpoalxyd	13	53	ART	art	NN
cord-032438-cpoalxyd	13	54	initiation	initiation	NN
cord-032438-cpoalxyd	13	55	at	at	IN
cord-032438-cpoalxyd	13	56	the	the	DT
cord-032438-cpoalxyd	13	57	clinic	clinic	NN
cord-032438-cpoalxyd	13	58	with	with	IN
cord-032438-cpoalxyd	13	59	community	community	NN
cord-032438-cpoalxyd	13	60	monitoring	monitoring	NN
cord-032438-cpoalxyd	13	61	and	and	CC
cord-032438-cpoalxyd	13	62	resupply	resupply	NN
cord-032438-cpoalxyd	13	63	)	)	-RRB-
cord-032438-cpoalxyd	13	64	,	,	,
cord-032438-cpoalxyd	13	65	and	and	CC
cord-032438-cpoalxyd	13	66	with	with	IN
cord-032438-cpoalxyd	13	67	standard	standard	JJ
cord-032438-cpoalxyd	13	68	clinicbased	clinicbased	JJ
cord-032438-cpoalxyd	13	69	ART	art	NN
cord-032438-cpoalxyd	13	70	delivery	delivery	NN
cord-032438-cpoalxyd	13	71	among	among	IN
cord-032438-cpoalxyd	13	72	individuals	individual	NNS
cord-032438-cpoalxyd	13	73	from	from	IN
cord-032438-cpoalxyd	13	74	South	South	NNP
cord-032438-cpoalxyd	13	75	Africa	Africa	NNP
cord-032438-cpoalxyd	13	76	and	and	CC
cord-032438-cpoalxyd	13	77	Uganda	Uganda	NNP
cord-032438-cpoalxyd	13	78	with	with	IN
cord-032438-cpoalxyd	13	79	detectable	detectable	JJ
cord-032438-cpoalxyd	13	80	HIV	HIV	NNP
cord-032438-cpoalxyd	13	81	viral	viral	JJ
cord-032438-cpoalxyd	13	82	load	load	NN
cord-032438-cpoalxyd	13	83	.	.	.
cord-032438-cpoalxyd	14	1	2	2	LS
cord-032438-cpoalxyd	15	1	The	the	DT
cord-032438-cpoalxyd	15	2	investigators	investigator	NNS
cord-032438-cpoalxyd	15	3	hypothesised	hypothesise	VBD
cord-032438-cpoalxyd	15	4	that	that	IN
cord-032438-cpoalxyd	15	5	community	community	NN
cord-032438-cpoalxyd	15	6	-	-	HYPH
cord-032438-cpoalxyd	15	7	based	base	VBN
cord-032438-cpoalxyd	15	8	ART	art	NN
cord-032438-cpoalxyd	15	9	could	could	MD
cord-032438-cpoalxyd	15	10	overcome	overcome	VB
cord-032438-cpoalxyd	15	11	logistical	logistical	JJ
cord-032438-cpoalxyd	15	12	barriers	barrier	NNS
cord-032438-cpoalxyd	15	13	,	,	,
cord-032438-cpoalxyd	15	14	simplify	simplify	VB
cord-032438-cpoalxyd	15	15	monitoring	monitoring	NN
cord-032438-cpoalxyd	15	16	and	and	CC
cord-032438-cpoalxyd	15	17	ART	art	NN
cord-032438-cpoalxyd	15	18	resupply	resupply	NN
cord-032438-cpoalxyd	15	19	,	,	,
cord-032438-cpoalxyd	15	20	and	and	CC
cord-032438-cpoalxyd	15	21	increase	increase	VB
cord-032438-cpoalxyd	15	22	viral	viral	JJ
cord-032438-cpoalxyd	15	23	suppression	suppression	NN
cord-032438-cpoalxyd	15	24	rates	rate	NNS
cord-032438-cpoalxyd	15	25	,	,	,
cord-032438-cpoalxyd	15	26	especially	especially	RB
cord-032438-cpoalxyd	15	27	among	among	IN
cord-032438-cpoalxyd	15	28	men	man	NNS
cord-032438-cpoalxyd	15	29	,	,	,
cord-032438-cpoalxyd	15	30	enough	enough	RB
cord-032438-cpoalxyd	15	31	to	to	TO
cord-032438-cpoalxyd	15	32	make	make	VB
cord-032438-cpoalxyd	15	33	communitybased	communitybased	JJ
cord-032438-cpoalxyd	15	34	interventions	intervention	NNS
cord-032438-cpoalxyd	15	35	cost	cost	NN
cord-032438-cpoalxyd	15	36	-	-	HYPH
cord-032438-cpoalxyd	15	37	effective	effective	JJ
cord-032438-cpoalxyd	15	38	.	.	.
cord-032438-cpoalxyd	16	1	They	-PRON-	PRP
cord-032438-cpoalxyd	16	2	found	find	VBD
cord-032438-cpoalxyd	16	3	that	that	IN
cord-032438-cpoalxyd	16	4	community	community	NN
cord-032438-cpoalxyd	16	5	-	-	HYPH
cord-032438-cpoalxyd	16	6	based	base	VBN
cord-032438-cpoalxyd	16	7	initiation	initiation	NN
cord-032438-cpoalxyd	16	8	and	and	CC
cord-032438-cpoalxyd	16	9	treatment	treatment	NN
cord-032438-cpoalxyd	16	10	significantly	significantly	RB
cord-032438-cpoalxyd	16	11	increased	increase	VBD
cord-032438-cpoalxyd	16	12	viral	viral	JJ
cord-032438-cpoalxyd	16	13	suppression	suppression	NN
cord-032438-cpoalxyd	16	14	compared	compare	VBN
cord-032438-cpoalxyd	16	15	with	with	IN
cord-032438-cpoalxyd	16	16	standard	standard	JJ
cord-032438-cpoalxyd	16	17	clinic	clinic	NN
cord-032438-cpoalxyd	16	18	-	-	HYPH
cord-032438-cpoalxyd	16	19	based	base	VBN
cord-032438-cpoalxyd	16	20	care	care	NN
cord-032438-cpoalxyd	16	21	among	among	IN
cord-032438-cpoalxyd	16	22	all	all	DT
cord-032438-cpoalxyd	16	23	participants	participant	NNS
cord-032438-cpoalxyd	16	24	from	from	IN
cord-032438-cpoalxyd	16	25	63·1	63·1	CD
cord-032438-cpoalxyd	16	26	%	%	NN
cord-032438-cpoalxyd	16	27	to	to	IN
cord-032438-cpoalxyd	16	28	73·9	73·9	CD
cord-032438-cpoalxyd	16	29	%	%	NN
cord-032438-cpoalxyd	16	30	,	,	,
cord-032438-cpoalxyd	16	31	and	and	CC
cord-032438-cpoalxyd	16	32	among	among	IN
cord-032438-cpoalxyd	16	33	men	man	NNS
cord-032438-cpoalxyd	16	34	from	from	IN
cord-032438-cpoalxyd	16	35	54·3	54·3	CD
cord-032438-cpoalxyd	16	36	%	%	NN
cord-032438-cpoalxyd	16	37	to	to	IN
cord-032438-cpoalxyd	16	38	73·2	73·2	CD
cord-032438-cpoalxyd	16	39	%	%	NN
cord-032438-cpoalxyd	16	40	.	.	.
cord-032438-cpoalxyd	17	1	The	the	DT
cord-032438-cpoalxyd	17	2	hybrid	hybrid	JJ
cord-032438-cpoalxyd	17	3	approach	approach	NN
cord-032438-cpoalxyd	17	4	registered	register	VBD
cord-032438-cpoalxyd	17	5	smaller	smaller	RBR
cord-032438-cpoalxyd	17	6	but	but	CC
cord-032438-cpoalxyd	17	7	similar	similar	JJ
cord-032438-cpoalxyd	17	8	effects	effect	NNS
cord-032438-cpoalxyd	17	9	.	.	.
cord-032438-cpoalxyd	18	1	The	the	DT
cord-032438-cpoalxyd	18	2	report	report	NN
cord-032438-cpoalxyd	18	3	of	of	IN
cord-032438-cpoalxyd	18	4	the	the	DT
cord-032438-cpoalxyd	18	5	DO	DO	NNP
cord-032438-cpoalxyd	18	6	-	-	HYPH
cord-032438-cpoalxyd	18	7	ART	art	NN
cord-032438-cpoalxyd	18	8	study	study	NN
cord-032438-cpoalxyd	18	9	contributes	contribute	VBZ
cord-032438-cpoalxyd	18	10	to	to	IN
cord-032438-cpoalxyd	18	11	a	a	DT
cord-032438-cpoalxyd	18	12	growing	grow	VBG
cord-032438-cpoalxyd	18	13	body	body	NN
cord-032438-cpoalxyd	18	14	of	of	IN
cord-032438-cpoalxyd	18	15	literature	literature	NN
cord-032438-cpoalxyd	18	16	showing	show	VBG
cord-032438-cpoalxyd	18	17	that	that	IN
cord-032438-cpoalxyd	18	18	communitybased	communitybase	VBN
cord-032438-cpoalxyd	18	19	interventions	intervention	NNS
cord-032438-cpoalxyd	18	20	result	result	VBP
cord-032438-cpoalxyd	18	21	in	in	IN
cord-032438-cpoalxyd	18	22	similar	similar	JJ
cord-032438-cpoalxyd	18	23	or	or	CC
cord-032438-cpoalxyd	18	24	improved	improved	JJ
cord-032438-cpoalxyd	18	25	patient	patient	JJ
cord-032438-cpoalxyd	18	26	outcomes	outcome	NNS
cord-032438-cpoalxyd	18	27	compared	compare	VBN
cord-032438-cpoalxyd	18	28	with	with	IN
cord-032438-cpoalxyd	18	29	clinic	clinic	NN
cord-032438-cpoalxyd	18	30	-	-	HYPH
cord-032438-cpoalxyd	18	31	based	base	VBN
cord-032438-cpoalxyd	18	32	ART	art	NN
cord-032438-cpoalxyd	18	33	delivery	delivery	NN
cord-032438-cpoalxyd	18	34	.	.	.
cord-032438-cpoalxyd	19	1	3	3	CD
cord-032438-cpoalxyd	19	2	,	,	,
cord-032438-cpoalxyd	19	3	4	4	CD
cord-032438-cpoalxyd	19	4	Home	home	NN
cord-032438-cpoalxyd	19	5	-	-	HYPH
cord-032438-cpoalxyd	19	6	based	base	VBN
cord-032438-cpoalxyd	19	7	,	,	,
cord-032438-cpoalxyd	19	8	same	same	JJ
cord-032438-cpoalxyd	19	9	-	-	HYPH
cord-032438-cpoalxyd	19	10	day	day	NN
cord-032438-cpoalxyd	19	11	ART	art	NN
cord-032438-cpoalxyd	19	12	initiation	initiation	NN
cord-032438-cpoalxyd	19	13	integrated	integrate	VBN
cord-032438-cpoalxyd	19	14	with	with	IN
cord-032438-cpoalxyd	19	15	community	community	NN
cord-032438-cpoalxyd	19	16	-	-	HYPH
cord-032438-cpoalxyd	19	17	based	base	VBN
cord-032438-cpoalxyd	19	18	HIV	HIV	NNP
cord-032438-cpoalxyd	19	19	testing	test	VBG
cord-032438-cpoalxyd	19	20	improved	improve	VBN
cord-032438-cpoalxyd	19	21	viral	viral	JJ
cord-032438-cpoalxyd	19	22	suppression	suppression	NN
cord-032438-cpoalxyd	19	23	at	at	IN
cord-032438-cpoalxyd	19	24	12	12	CD
cord-032438-cpoalxyd	19	25	months	month	NNS
cord-032438-cpoalxyd	19	26	in	in	IN
cord-032438-cpoalxyd	19	27	a	a	DT
cord-032438-cpoalxyd	19	28	trial	trial	NN
cord-032438-cpoalxyd	19	29	in	in	IN
cord-032438-cpoalxyd	19	30	Lesotho	Lesotho	NNP
cord-032438-cpoalxyd	19	31	.	.	.
cord-032438-cpoalxyd	20	1	5	5	CD
cord-032438-cpoalxyd	20	2	Community	community	NN
cord-032438-cpoalxyd	20	3	-	-	HYPH
cord-032438-cpoalxyd	20	4	based	base	VBN
cord-032438-cpoalxyd	20	5	HIV	HIV	NNP
cord-032438-cpoalxyd	20	6	care	care	NN
cord-032438-cpoalxyd	20	7	using	use	VBG
cord-032438-cpoalxyd	20	8	differentiated	differentiated	JJ
cord-032438-cpoalxyd	20	9	service	service	NN
cord-032438-cpoalxyd	20	10	delivery	delivery	NN
cord-032438-cpoalxyd	20	11	models	model	NNS
cord-032438-cpoalxyd	20	12	,	,	,
cord-032438-cpoalxyd	20	13	including	include	VBG
cord-032438-cpoalxyd	20	14	community	community	NN
cord-032438-cpoalxyd	20	15	-	-	HYPH
cord-032438-cpoalxyd	20	16	based	base	VBN
cord-032438-cpoalxyd	20	17	multimonth	multimonth	NNP
cord-032438-cpoalxyd	20	18	ART	ART	NNP
cord-032438-cpoalxyd	20	19	dispensing	dispensing	NN
cord-032438-cpoalxyd	20	20	,	,	,
cord-032438-cpoalxyd	20	21	have	have	VBP
cord-032438-cpoalxyd	20	22	been	be	VBN
cord-032438-cpoalxyd	20	23	shown	show	VBN
cord-032438-cpoalxyd	20	24	to	to	TO
cord-032438-cpoalxyd	20	25	have	have	VB
cord-032438-cpoalxyd	20	26	favourable	favourable	JJ
cord-032438-cpoalxyd	20	27	outcomes	outcome	NNS
cord-032438-cpoalxyd	20	28	6	6	CD
cord-032438-cpoalxyd	20	29	and	and	CC
cord-032438-cpoalxyd	20	30	result	result	VB
cord-032438-cpoalxyd	20	31	in	in	IN
cord-032438-cpoalxyd	20	32	cost	cost	NN
cord-032438-cpoalxyd	20	33	savings	saving	NNS
cord-032438-cpoalxyd	20	34	to	to	IN
cord-032438-cpoalxyd	20	35	both	both	DT
cord-032438-cpoalxyd	20	36	patients	patient	NNS
cord-032438-cpoalxyd	20	37	and	and	CC
cord-032438-cpoalxyd	20	38	providers	provider	NNS
cord-032438-cpoalxyd	20	39	.	.	.
cord-032438-cpoalxyd	21	1	7	7	CD
cord-032438-cpoalxyd	22	1	However	however	RB
cord-032438-cpoalxyd	22	2	,	,	,
cord-032438-cpoalxyd	22	3	most	most	RBS
cord-032438-cpoalxyd	22	4	communitybased	communitybased	JJ
cord-032438-cpoalxyd	22	5	differentiated	differentiated	JJ
cord-032438-cpoalxyd	22	6	service	service	NN
cord-032438-cpoalxyd	22	7	delivery	delivery	NN
cord-032438-cpoalxyd	22	8	models	model	NNS
cord-032438-cpoalxyd	22	9	for	for	IN
cord-032438-cpoalxyd	22	10	ART	art	NN
cord-032438-cpoalxyd	22	11	delivery	delivery	NN
cord-032438-cpoalxyd	22	12	have	have	VBP
cord-032438-cpoalxyd	22	13	been	be	VBN
cord-032438-cpoalxyd	22	14	developed	develop	VBN
cord-032438-cpoalxyd	22	15	for	for	IN
cord-032438-cpoalxyd	22	16	patients	patient	NNS
cord-032438-cpoalxyd	22	17	who	who	WP
cord-032438-cpoalxyd	22	18	are	be	VBP
cord-032438-cpoalxyd	22	19	already	already	RB
cord-032438-cpoalxyd	22	20	stable	stable	JJ
cord-032438-cpoalxyd	22	21	on	on	IN
cord-032438-cpoalxyd	22	22	ART	art	NN
cord-032438-cpoalxyd	22	23	,	,	,
cord-032438-cpoalxyd	22	24	and	and	CC
cord-032438-cpoalxyd	22	25	the	the	DT
cord-032438-cpoalxyd	22	26	most	most	RBS
cord-032438-cpoalxyd	22	27	important	important	JJ
cord-032438-cpoalxyd	22	28	contribution	contribution	NN
cord-032438-cpoalxyd	22	29	of	of	IN
cord-032438-cpoalxyd	22	30	the	the	DT
cord-032438-cpoalxyd	22	31	study	study	NN
cord-032438-cpoalxyd	22	32	by	by	IN
cord-032438-cpoalxyd	22	33	Barnabas	Barnabas	NNP
cord-032438-cpoalxyd	22	34	and	and	CC
cord-032438-cpoalxyd	22	35	colleagues	colleague	NNS
cord-032438-cpoalxyd	22	36	is	be	VBZ
cord-032438-cpoalxyd	22	37	that	that	IN
cord-032438-cpoalxyd	22	38	community	community	NN
cord-032438-cpoalxyd	22	39	-	-	HYPH
cord-032438-cpoalxyd	22	40	based	base	VBN
cord-032438-cpoalxyd	22	41	,	,	,
cord-032438-cpoalxyd	22	42	same	same	JJ
cord-032438-cpoalxyd	22	43	-	-	HYPH
cord-032438-cpoalxyd	22	44	day	day	NN
cord-032438-cpoalxyd	22	45	ART	art	NN
cord-032438-cpoalxyd	22	46	initiation	initiation	NN
cord-032438-cpoalxyd	22	47	in	in	IN
cord-032438-cpoalxyd	22	48	individuals	individual	NNS
cord-032438-cpoalxyd	22	49	with	with	IN
cord-032438-cpoalxyd	22	50	elevated	elevated	JJ
cord-032438-cpoalxyd	22	51	viral	viral	JJ
cord-032438-cpoalxyd	22	52	load	load	NN
cord-032438-cpoalxyd	22	53	was	be	VBD
cord-032438-cpoalxyd	22	54	safe	safe	JJ
cord-032438-cpoalxyd	22	55	and	and	CC
cord-032438-cpoalxyd	22	56	resulted	result	VBD
cord-032438-cpoalxyd	22	57	in	in	IN
cord-032438-cpoalxyd	22	58	improved	improve	VBN
cord-032438-cpoalxyd	22	59	viral	viral	JJ
cord-032438-cpoalxyd	22	60	suppression	suppression	NN
cord-032438-cpoalxyd	22	61	after	after	IN
cord-032438-cpoalxyd	22	62	12	12	CD
cord-032438-cpoalxyd	22	63	months	month	NNS
cord-032438-cpoalxyd	22	64	,	,	,
cord-032438-cpoalxyd	22	65	particularly	particularly	RB
cord-032438-cpoalxyd	22	66	among	among	IN
cord-032438-cpoalxyd	22	67	men	man	NNS
cord-032438-cpoalxyd	22	68	.	.	.
cord-032438-cpoalxyd	23	1	With	with	IN
cord-032438-cpoalxyd	23	2	these	these	DT
cord-032438-cpoalxyd	23	3	promising	promising	JJ
cord-032438-cpoalxyd	23	4	results	result	NNS
cord-032438-cpoalxyd	23	5	,	,	,
cord-032438-cpoalxyd	23	6	the	the	DT
cord-032438-cpoalxyd	23	7	next	next	JJ
cord-032438-cpoalxyd	23	8	questions	question	NNS
cord-032438-cpoalxyd	23	9	are	be	VBP
cord-032438-cpoalxyd	23	10	whether	whether	IN
cord-032438-cpoalxyd	23	11	,	,	,
cord-032438-cpoalxyd	23	12	where	where	WRB
cord-032438-cpoalxyd	23	13	,	,	,
cord-032438-cpoalxyd	23	14	when	when	WRB
cord-032438-cpoalxyd	23	15	,	,	,
cord-032438-cpoalxyd	23	16	and	and	CC
cord-032438-cpoalxyd	23	17	how	how	WRB
cord-032438-cpoalxyd	23	18	global	global	JJ
cord-032438-cpoalxyd	23	19	public	public	JJ
cord-032438-cpoalxyd	23	20	implementers	implementer	NNS
cord-032438-cpoalxyd	23	21	should	should	MD
cord-032438-cpoalxyd	23	22	scale	scale	VB
cord-032438-cpoalxyd	23	23	up	up	RP
cord-032438-cpoalxyd	23	24	the	the	DT
cord-032438-cpoalxyd	23	25	DO	DO	NNP
cord-032438-cpoalxyd	23	26	-	-	HYPH
cord-032438-cpoalxyd	23	27	ART	art	NN
cord-032438-cpoalxyd	23	28	approach	approach	NN
cord-032438-cpoalxyd	23	29	,	,	,
cord-032438-cpoalxyd	23	30	particularly	particularly	RB
cord-032438-cpoalxyd	23	31	among	among	IN
cord-032438-cpoalxyd	23	32	men	man	NNS
cord-032438-cpoalxyd	23	33	.	.	.
cord-032438-cpoalxyd	24	1	The	the	DT
cord-032438-cpoalxyd	24	2	answers	answer	NNS
cord-032438-cpoalxyd	24	3	,	,	,
cord-032438-cpoalxyd	24	4	however	however	RB
cord-032438-cpoalxyd	24	5	,	,	,
cord-032438-cpoalxyd	24	6	depend	depend	VBP
cord-032438-cpoalxyd	24	7	not	not	RB
cord-032438-cpoalxyd	24	8	only	only	RB
cord-032438-cpoalxyd	24	9	on	on	IN
cord-032438-cpoalxyd	24	10	the	the	DT
cord-032438-cpoalxyd	24	11	rigour	rigour	NN
cord-032438-cpoalxyd	24	12	or	or	CC
cord-032438-cpoalxyd	24	13	internal	internal	JJ
cord-032438-cpoalxyd	24	14	validity	validity	NN
cord-032438-cpoalxyd	24	15	of	of	IN
cord-032438-cpoalxyd	24	16	the	the	DT
cord-032438-cpoalxyd	24	17	study	study	NN
cord-032438-cpoalxyd	24	18	(	(	-LRB-
cord-032438-cpoalxyd	24	19	for	for	IN
cord-032438-cpoalxyd	24	20	which	which	WDT
cord-032438-cpoalxyd	24	21	the	the	DT
cord-032438-cpoalxyd	24	22	investigators	investigator	NNS
cord-032438-cpoalxyd	24	23	should	should	MD
cord-032438-cpoalxyd	24	24	be	be	VB
cord-032438-cpoalxyd	24	25	applauded	applaud	VBN
cord-032438-cpoalxyd	24	26	)	)	-RRB-
cord-032438-cpoalxyd	24	27	but	but	CC
cord-032438-cpoalxyd	24	28	also	also	RB
cord-032438-cpoalxyd	24	29	on	on	IN
cord-032438-cpoalxyd	24	30	the	the	DT
cord-032438-cpoalxyd	24	31	external	external	JJ
cord-032438-cpoalxyd	24	32	validity	validity	NN
cord-032438-cpoalxyd	24	33	,	,	,
cord-032438-cpoalxyd	24	34	for	for	IN
cord-032438-cpoalxyd	24	35	which	which	WDT
cord-032438-cpoalxyd	24	36	some	some	DT
cord-032438-cpoalxyd	24	37	additional	additional	JJ
cord-032438-cpoalxyd	24	38	information	information	NN
cord-032438-cpoalxyd	24	39	would	would	MD
cord-032438-cpoalxyd	24	40	be	be	VB
cord-032438-cpoalxyd	24	41	useful	useful	JJ
cord-032438-cpoalxyd	24	42	.	.	.
cord-032438-cpoalxyd	25	1	Emerging	emerge	VBG
cord-032438-cpoalxyd	25	2	perspectives	perspective	NNS
cord-032438-cpoalxyd	25	3	in	in	IN
cord-032438-cpoalxyd	25	4	implementation	implementation	NN
cord-032438-cpoalxyd	25	5	research	research	NN
cord-032438-cpoalxyd	25	6	can	can	MD
cord-032438-cpoalxyd	25	7	help	help	VB
cord-032438-cpoalxyd	25	8	position	position	VB
cord-032438-cpoalxyd	25	9	researchers	researcher	NNS
cord-032438-cpoalxyd	25	10	to	to	TO
cord-032438-cpoalxyd	25	11	offer	offer	VB
cord-032438-cpoalxyd	25	12	findings	finding	NNS
cord-032438-cpoalxyd	25	13	that	that	WDT
cord-032438-cpoalxyd	25	14	are	be	VBP
cord-032438-cpoalxyd	25	15	maximally	maximally	RB
cord-032438-cpoalxyd	25	16	interpretable	interpretable	JJ
cord-032438-cpoalxyd	25	17	in	in	IN
cord-032438-cpoalxyd	25	18	other	other	JJ
cord-032438-cpoalxyd	25	19	implementing	implement	VBG
cord-032438-cpoalxyd	25	20	contexts	context	NNS
cord-032438-cpoalxyd	25	21	that	that	WDT
cord-032438-cpoalxyd	25	22	differ	differ	VBP
cord-032438-cpoalxyd	25	23	by	by	IN
cord-032438-cpoalxyd	25	24	geographical	geographical	JJ
cord-032438-cpoalxyd	25	25	(	(	-LRB-
cord-032438-cpoalxyd	25	26	urban	urban	JJ
cord-032438-cpoalxyd	25	27	vs	vs	IN
cord-032438-cpoalxyd	25	28	rural	rural	JJ
cord-032438-cpoalxyd	25	29	)	)	-RRB-
cord-032438-cpoalxyd	25	30	,	,	,
cord-032438-cpoalxyd	25	31	economic	economic	JJ
cord-032438-cpoalxyd	25	32	(	(	-LRB-
cord-032438-cpoalxyd	25	33	Kenya	Kenya	NNP
cord-032438-cpoalxyd	25	34	vs	vs	IN
cord-032438-cpoalxyd	25	35	Mozambique	Mozambique	NNP
cord-032438-cpoalxyd	25	36	)	)	-RRB-
cord-032438-cpoalxyd	25	37	,	,	,
cord-032438-cpoalxyd	25	38	and	and	CC
cord-032438-cpoalxyd	25	39	social	social	JJ
cord-032438-cpoalxyd	25	40	factors	factor	NNS
cord-032438-cpoalxyd	25	41	-	-	:
cord-032438-cpoalxyd	25	42	what	what	WP
cord-032438-cpoalxyd	25	43	do	do	VBP
cord-032438-cpoalxyd	25	44	these	these	DT
cord-032438-cpoalxyd	25	45	perspectives	perspective	NNS
cord-032438-cpoalxyd	25	46	suggest	suggest	VB
cord-032438-cpoalxyd	25	47	for	for	IN
cord-032438-cpoalxyd	25	48	future	future	JJ
cord-032438-cpoalxyd	25	49	research	research	NN
cord-032438-cpoalxyd	25	50	that	that	WDT
cord-032438-cpoalxyd	25	51	aims	aim	VBZ
cord-032438-cpoalxyd	25	52	to	to	TO
cord-032438-cpoalxyd	25	53	influence	influence	VB
cord-032438-cpoalxyd	25	54	execution	execution	NN
cord-032438-cpoalxyd	25	55	of	of	IN
cord-032438-cpoalxyd	25	56	the	the	DT
cord-032438-cpoalxyd	25	57	HIV	HIV	NNP
cord-032438-cpoalxyd	25	58	response	response	NN
cord-032438-cpoalxyd	25	59	?	?	.
cord-032438-cpoalxyd	26	1	Mechanisms	mechanism	NNS
cord-032438-cpoalxyd	26	2	can	can	MD
cord-032438-cpoalxyd	26	3	inform	inform	VB
cord-032438-cpoalxyd	26	4	decisions	decision	NNS
cord-032438-cpoalxyd	26	5	about	about	IN
cord-032438-cpoalxyd	26	6	scale	scale	NN
cord-032438-cpoalxyd	26	7	up	up	RP
cord-032438-cpoalxyd	26	8	.	.	.
cord-032438-cpoalxyd	27	1	First	first	RB
cord-032438-cpoalxyd	27	2	,	,	,
cord-032438-cpoalxyd	27	3	an	an	DT
cord-032438-cpoalxyd	27	4	important	important	JJ
cord-032438-cpoalxyd	27	5	insight	insight	NN
cord-032438-cpoalxyd	27	6	is	be	VBZ
cord-032438-cpoalxyd	27	7	that	that	IN
cord-032438-cpoalxyd	27	8	the	the	DT
cord-032438-cpoalxyd	27	9	external	external	JJ
cord-032438-cpoalxyd	27	10	validity	validity	NN
cord-032438-cpoalxyd	27	11	of	of	IN
cord-032438-cpoalxyd	27	12	a	a	DT
cord-032438-cpoalxyd	27	13	finding	finding	NN
cord-032438-cpoalxyd	27	14	depends	depend	VBZ
cord-032438-cpoalxyd	27	15	on	on	IN
cord-032438-cpoalxyd	27	16	the	the	DT
cord-032438-cpoalxyd	27	17	mechanism	mechanism	NN
cord-032438-cpoalxyd	27	18	of	of	IN
cord-032438-cpoalxyd	27	19	effect	effect	NN
cord-032438-cpoalxyd	27	20	.	.	.
cord-032438-cpoalxyd	28	1	In	in	IN
cord-032438-cpoalxyd	28	2	this	this	DT
cord-032438-cpoalxyd	28	3	study	study	NN
cord-032438-cpoalxyd	28	4	,	,	,
cord-032438-cpoalxyd	28	5	more	more	JJR
cord-032438-cpoalxyd	28	6	information	information	NN
cord-032438-cpoalxyd	28	7	about	about	IN
cord-032438-cpoalxyd	28	8	how	how	WRB
cord-032438-cpoalxyd	28	9	communitybased	communitybase	VBN
cord-032438-cpoalxyd	28	10	approaches	approach	NNS
cord-032438-cpoalxyd	28	11	improved	improve	VBD
cord-032438-cpoalxyd	28	12	viral	viral	JJ
cord-032438-cpoalxyd	28	13	suppression	suppression	NN
cord-032438-cpoalxyd	28	14	would	would	MD
cord-032438-cpoalxyd	28	15	be	be	VB
cord-032438-cpoalxyd	28	16	helpful	helpful	JJ
cord-032438-cpoalxyd	28	17	.	.	.
cord-032438-cpoalxyd	29	1	If	if	IN
cord-032438-cpoalxyd	29	2	the	the	DT
cord-032438-cpoalxyd	29	3	community	community	NN
cord-032438-cpoalxyd	29	4	-	-	HYPH
cord-032438-cpoalxyd	29	5	based	base	VBN
cord-032438-cpoalxyd	29	6	approach	approach	NN
cord-032438-cpoalxyd	29	7	worked	work	VBD
cord-032438-cpoalxyd	29	8	through	through	IN
cord-032438-cpoalxyd	29	9	availing	avail	VBG
cord-032438-cpoalxyd	29	10	ART	art	NN
cord-032438-cpoalxyd	29	11	to	to	IN
cord-032438-cpoalxyd	29	12	patients	patient	NNS
cord-032438-cpoalxyd	29	13	unable	unable	JJ
cord-032438-cpoalxyd	29	14	or	or	CC
cord-032438-cpoalxyd	29	15	unwilling	unwilling	JJ
cord-032438-cpoalxyd	29	16	to	to	TO
cord-032438-cpoalxyd	29	17	get	get	VB
cord-032438-cpoalxyd	29	18	to	to	IN
cord-032438-cpoalxyd	29	19	a	a	DT
cord-032438-cpoalxyd	29	20	clinic	clinic	NN
cord-032438-cpoalxyd	29	21	,	,	,
cord-032438-cpoalxyd	29	22	then	then	RB
cord-032438-cpoalxyd	29	23	this	this	DT
cord-032438-cpoalxyd	29	24	approach	approach	NN
cord-032438-cpoalxyd	29	25	is	be	VBZ
cord-032438-cpoalxyd	29	26	most	most	RBS
cord-032438-cpoalxyd	29	27	applicable	applicable	JJ
cord-032438-cpoalxyd	29	28	to	to	IN
cord-032438-cpoalxyd	29	29	rural	rural	JJ
cord-032438-cpoalxyd	29	30	settings	setting	NNS
cord-032438-cpoalxyd	29	31	,	,	,
cord-032438-cpoalxyd	29	32	where	where	WRB
cord-032438-cpoalxyd	29	33	distance	distance	NN
cord-032438-cpoalxyd	29	34	is	be	VBZ
cord-032438-cpoalxyd	29	35	important	important	JJ
cord-032438-cpoalxyd	29	36	.	.	.
cord-032438-cpoalxyd	30	1	Conversely	conversely	RB
cord-032438-cpoalxyd	30	2	,	,	,
cord-032438-cpoalxyd	30	3	if	if	IN
cord-032438-cpoalxyd	30	4	patients	patient	NNS
cord-032438-cpoalxyd	30	5	in	in	IN
cord-032438-cpoalxyd	30	6	the	the	DT
cord-032438-cpoalxyd	30	7	standard	standard	NN
cord-032438-cpoalxyd	30	8	of	of	IN
cord-032438-cpoalxyd	30	9	care	care	NN
cord-032438-cpoalxyd	30	10	arm	arm	NN
cord-032438-cpoalxyd	30	11	of	of	IN
cord-032438-cpoalxyd	30	12	the	the	DT
cord-032438-cpoalxyd	30	13	trial	trial	NN
cord-032438-cpoalxyd	30	14	reached	reach	VBD
cord-032438-cpoalxyd	30	15	the	the	DT
cord-032438-cpoalxyd	30	16	clinic	clinic	NN
cord-032438-cpoalxyd	30	17	but	but	CC
cord-032438-cpoalxyd	30	18	did	do	VBD
cord-032438-cpoalxyd	30	19	not	not	RB
cord-032438-cpoalxyd	30	20	start	start	VB
cord-032438-cpoalxyd	30	21	ART	art	NN
cord-032438-cpoalxyd	30	22	due	due	JJ
cord-032438-cpoalxyd	30	23	to	to	IN
cord-032438-cpoalxyd	30	24	lengthy	lengthy	JJ
cord-032438-cpoalxyd	30	25	preparation	preparation	NN
cord-032438-cpoalxyd	30	26	practices	practice	NNS
cord-032438-cpoalxyd	30	27	,	,	,
cord-032438-cpoalxyd	30	28	the	the	DT
cord-032438-cpoalxyd	30	29	observed	observed	JJ
cord-032438-cpoalxyd	30	30	effects	effect	NNS
cord-032438-cpoalxyd	30	31	might	may	MD
cord-032438-cpoalxyd	30	32	be	be	VB
cord-032438-cpoalxyd	30	33	attenuated	attenuate	VBN
cord-032438-cpoalxyd	30	34	since	since	IN
cord-032438-cpoalxyd	30	35	immediate	immediate	JJ
cord-032438-cpoalxyd	30	36	ART	art	NN
cord-032438-cpoalxyd	30	37	initiation	initiation	NN
cord-032438-cpoalxyd	30	38	in	in	IN
cord-032438-cpoalxyd	30	39	the	the	DT
cord-032438-cpoalxyd	30	40	clinic	clinic	NN
cord-032438-cpoalxyd	30	41	has	have	VBZ
cord-032438-cpoalxyd	30	42	become	become	VBN
cord-032438-cpoalxyd	30	43	the	the	DT
cord-032438-cpoalxyd	30	44	norm	norm	NN
cord-032438-cpoalxyd	30	45	over	over	IN
cord-032438-cpoalxyd	30	46	the	the	DT
cord-032438-cpoalxyd	30	47	past	past	JJ
cord-032438-cpoalxyd	30	48	2	2	CD
cord-032438-cpoalxyd	30	49	years	year	NNS
cord-032438-cpoalxyd	30	50	.	.	.
cord-032438-cpoalxyd	31	1	Second	second	JJ
cord-032438-cpoalxyd	31	2	,	,	,
cord-032438-cpoalxyd	31	3	so	so	RB
cord-032438-cpoalxyd	31	4	-	-	HYPH
cord-032438-cpoalxyd	31	5	called	call	VBN
cord-032438-cpoalxyd	31	6	adjunctive	adjunctive	JJ
cord-032438-cpoalxyd	31	7	practices	practice	NNS
cord-032438-cpoalxyd	31	8	that	that	WDT
cord-032438-cpoalxyd	31	9	accompany	accompany	VBP
cord-032438-cpoalxyd	31	10	study	study	NN
cord-032438-cpoalxyd	31	11	interventions	intervention	NNS
cord-032438-cpoalxyd	31	12	but	but	CC
cord-032438-cpoalxyd	31	13	are	be	VBP
cord-032438-cpoalxyd	31	14	not	not	RB
cord-032438-cpoalxyd	31	15	explicitly	explicitly	RB
cord-032438-cpoalxyd	31	16	considered	consider	VBN
cord-032438-cpoalxyd	31	17	important	important	JJ
cord-032438-cpoalxyd	31	18	complicate	complicate	VB
cord-032438-cpoalxyd	31	19	external	external	JJ
cord-032438-cpoalxyd	31	20	validity	validity	NN
cord-032438-cpoalxyd	31	21	.	.	.
cord-032438-cpoalxyd	32	1	In	in	IN
cord-032438-cpoalxyd	32	2	the	the	DT
cord-032438-cpoalxyd	32	3	DO	DO	NNP
cord-032438-cpoalxyd	32	4	-	-	HYPH
cord-032438-cpoalxyd	32	5	ART	art	NN
cord-032438-cpoalxyd	32	6	study	study	NN
cord-032438-cpoalxyd	32	7	,	,	,
cord-032438-cpoalxyd	32	8	patients	patient	NNS
cord-032438-cpoalxyd	32	9	starting	start	VBG
cord-032438-cpoalxyd	32	10	ART	art	NN
cord-032438-cpoalxyd	32	11	in	in	IN
cord-032438-cpoalxyd	32	12	the	the	DT
cord-032438-cpoalxyd	32	13	community	community	NN
cord-032438-cpoalxyd	32	14	also	also	RB
cord-032438-cpoalxyd	32	15	received	receive	VBD
cord-032438-cpoalxyd	32	16	text	text	NN
cord-032438-cpoalxyd	32	17	message	message	NN
cord-032438-cpoalxyd	32	18	appointment	appointment	NN
cord-032438-cpoalxyd	32	19	reminders	reminder	NNS
cord-032438-cpoalxyd	32	20	,	,	,
cord-032438-cpoalxyd	32	21	facilitated	facilitate	VBN
cord-032438-cpoalxyd	32	22	rescheduling	rescheduling	NN
cord-032438-cpoalxyd	32	23	,	,	,
cord-032438-cpoalxyd	32	24	follow	follow	VB
cord-032438-cpoalxyd	32	25	-	-	HYPH
cord-032438-cpoalxyd	32	26	up	up	NN
cord-032438-cpoalxyd	32	27	monitoring	monitoring	NN
cord-032438-cpoalxyd	32	28	calls	call	NNS
cord-032438-cpoalxyd	32	29	,	,	,
cord-032438-cpoalxyd	32	30	and	and	CC
cord-032438-cpoalxyd	32	31	potentially	potentially	RB
cord-032438-cpoalxyd	32	32	more	more	RBR
cord-032438-cpoalxyd	32	33	intensive	intensive	JJ
cord-032438-cpoalxyd	32	34	counselling	counselling	NN
cord-032438-cpoalxyd	32	35	.	.	.
cord-032438-cpoalxyd	33	1	Unless	unless	IN
cord-032438-cpoalxyd	33	2	community	community	NN
cord-032438-cpoalxyd	33	3	-	-	HYPH
cord-032438-cpoalxyd	33	4	based	base	VBN
cord-032438-cpoalxyd	33	5	ART	art	NN
cord-032438-cpoalxyd	33	6	initiation	initiation	NN
cord-032438-cpoalxyd	33	7	is	be	VBZ
cord-032438-cpoalxyd	33	8	universally	universally	RB
cord-032438-cpoalxyd	33	9	scaled	scale	VBN
cord-032438-cpoalxyd	33	10	up	up	RP
cord-032438-cpoalxyd	33	11	concomitantly	concomitantly	RB
cord-032438-cpoalxyd	33	12	with	with	IN
cord-032438-cpoalxyd	33	13	these	these	DT
cord-032438-cpoalxyd	33	14	adjunctive	adjunctive	JJ
cord-032438-cpoalxyd	33	15	practices	practice	NNS
cord-032438-cpoalxyd	33	16	,	,	,
cord-032438-cpoalxyd	33	17	the	the	DT
cord-032438-cpoalxyd	33	18	real	real	JJ
cord-032438-cpoalxyd	33	19	-	-	HYPH
cord-032438-cpoalxyd	33	20	world	world	NN
cord-032438-cpoalxyd	33	21	effects	effect	NNS
cord-032438-cpoalxyd	33	22	might	may	MD
cord-032438-cpoalxyd	33	23	show	show	VB
cord-032438-cpoalxyd	33	24	a	a	DT
cord-032438-cpoalxyd	33	25	drop	drop	NN
cord-032438-cpoalxyd	33	26	in	in	IN
cord-032438-cpoalxyd	33	27	ART	art	NN
cord-032438-cpoalxyd	33	28	compliance	compliance	NN
cord-032438-cpoalxyd	33	29	and	and	CC
cord-032438-cpoalxyd	33	30	viral	viral	JJ
cord-032438-cpoalxyd	33	31	suppression	suppression	NN
cord-032438-cpoalxyd	33	32	rates	rate	NNS
cord-032438-cpoalxyd	33	33	compared	compare	VBN
cord-032438-cpoalxyd	33	34	with	with	IN
cord-032438-cpoalxyd	33	35	trial	trial	NN
cord-032438-cpoalxyd	33	36	findings	finding	NNS
cord-032438-cpoalxyd	33	37	.	.	.
cord-032438-cpoalxyd	34	1	Parsimonious	parsimonious	JJ
cord-032438-cpoalxyd	34	2	intervention	intervention	NN
cord-032438-cpoalxyd	34	3	design	design	NN
cord-032438-cpoalxyd	34	4	could	could	MD
cord-032438-cpoalxyd	34	5	improve	improve	VB
cord-032438-cpoalxyd	34	6	generalisability	generalisability	NN
cord-032438-cpoalxyd	34	7	.	.	.
cord-032438-cpoalxyd	35	1	Third	third	RB
cord-032438-cpoalxyd	35	2	,	,	,
cord-032438-cpoalxyd	35	3	measuring	measure	VBG
cord-032438-cpoalxyd	35	4	and	and	CC
cord-032438-cpoalxyd	35	5	reporting	report	VBG
cord-032438-cpoalxyd	35	6	patient	patient	NN
cord-032438-cpoalxyd	35	7	preferences	preference	NNS
cord-032438-cpoalxyd	35	8	is	be	VBZ
cord-032438-cpoalxyd	35	9	also	also	RB
cord-032438-cpoalxyd	35	10	important	important	JJ
cord-032438-cpoalxyd	35	11	.	.	.
cord-032438-cpoalxyd	36	1	Someone	someone	NN
cord-032438-cpoalxyd	36	2	living	live	VBG
cord-032438-cpoalxyd	36	3	with	with	IN
cord-032438-cpoalxyd	36	4	stigma	stigma	NN
cord-032438-cpoalxyd	36	5	and	and	CC
cord-032438-cpoalxyd	36	6	near	near	IN
cord-032438-cpoalxyd	36	7	a	a	DT
cord-032438-cpoalxyd	36	8	clinic	clinic	NN
cord-032438-cpoalxyd	36	9	,	,	,
cord-032438-cpoalxyd	36	10	for	for	IN
cord-032438-cpoalxyd	36	11	example	example	NN
cord-032438-cpoalxyd	36	12	,	,	,
cord-032438-cpoalxyd	36	13	might	may	MD
cord-032438-cpoalxyd	36	14	have	have	VB
cord-032438-cpoalxyd	36	15	different	different	JJ
cord-032438-cpoalxyd	36	16	preferences	preference	NNS
cord-032438-cpoalxyd	36	17	for	for	IN
cord-032438-cpoalxyd	36	18	home	home	NN
cord-032438-cpoalxyd	36	19	-	-	HYPH
cord-032438-cpoalxyd	36	20	based	base	VBN
cord-032438-cpoalxyd	36	21	ART	art	NN
cord-032438-cpoalxyd	36	22	initiation	initiation	NN
cord-032438-cpoalxyd	36	23	than	than	IN
cord-032438-cpoalxyd	36	24	someone	someone	NN
cord-032438-cpoalxyd	36	25	living	live	VBG
cord-032438-cpoalxyd	36	26	far	far	RB
cord-032438-cpoalxyd	36	27	from	from	IN
cord-032438-cpoalxyd	36	28	a	a	DT
cord-032438-cpoalxyd	36	29	clinic	clinic	NN
cord-032438-cpoalxyd	36	30	.	.	.
cord-032438-cpoalxyd	37	1	In	in	IN
cord-032438-cpoalxyd	37	2	preference	preference	NN
cord-032438-cpoalxyd	37	3	-	-	HYPH
cord-032438-cpoalxyd	37	4	sensitive	sensitive	JJ
cord-032438-cpoalxyd	37	5	interventions	intervention	NNS
cord-032438-cpoalxyd	37	6	such	such	JJ
cord-032438-cpoalxyd	37	7	as	as	IN
cord-032438-cpoalxyd	37	8	these	these	DT
cord-032438-cpoalxyd	37	9	,	,	,
cord-032438-cpoalxyd	37	10	the	the	DT
cord-032438-cpoalxyd	37	11	comparison	comparison	NN
cord-032438-cpoalxyd	37	12	of	of	IN
cord-032438-cpoalxyd	37	13	interest	interest	NN
cord-032438-cpoalxyd	37	14	might	may	MD
cord-032438-cpoalxyd	37	15	not	not	RB
cord-032438-cpoalxyd	37	16	be	be	VB
cord-032438-cpoalxyd	37	17	between	between	IN
cord-032438-cpoalxyd	37	18	community	community	NN
cord-032438-cpoalxyd	37	19	-	-	HYPH
cord-032438-cpoalxyd	37	20	based	base	VBN
cord-032438-cpoalxyd	37	21	and	and	CC
cord-032438-cpoalxyd	37	22	clinic	clinic	NN
cord-032438-cpoalxyd	37	23	-	-	HYPH
cord-032438-cpoalxyd	37	24	based	base	VBN
cord-032438-cpoalxyd	37	25	ART	art	NN
cord-032438-cpoalxyd	37	26	initiation	initiation	NN
cord-032438-cpoalxyd	37	27	,	,	,
cord-032438-cpoalxyd	37	28	but	but	CC
cord-032438-cpoalxyd	37	29	rather	rather	RB
cord-032438-cpoalxyd	37	30	between	between	IN
cord-032438-cpoalxyd	37	31	a	a	DT
cord-032438-cpoalxyd	37	32	health	health	NN
cord-032438-cpoalxyd	37	33	system	system	NN
cord-032438-cpoalxyd	37	34	that	that	WDT
cord-032438-cpoalxyd	37	35	offers	offer	VBZ
cord-032438-cpoalxyd	37	36	both	both	DT
cord-032438-cpoalxyd	37	37	(	(	-LRB-
cord-032438-cpoalxyd	37	38	from	from	IN
cord-032438-cpoalxyd	37	39	which	which	WDT
cord-032438-cpoalxyd	37	40	patients	patient	NNS
cord-032438-cpoalxyd	37	41	could	could	MD
cord-032438-cpoalxyd	37	42	choose	choose	VB
cord-032438-cpoalxyd	37	43	)	)	-RRB-
cord-032438-cpoalxyd	37	44	versus	versus	IN
cord-032438-cpoalxyd	37	45	a	a	DT
cord-032438-cpoalxyd	37	46	system	system	NN
cord-032438-cpoalxyd	37	47	that	that	WDT
cord-032438-cpoalxyd	37	48	only	only	RB
cord-032438-cpoalxyd	37	49	offers	offer	VBZ
cord-032438-cpoalxyd	37	50	one	one	CD
cord-032438-cpoalxyd	37	51	-	-	HYPH
cord-032438-cpoalxyd	37	52	a	a	DT
cord-032438-cpoalxyd	37	53	concept	concept	NN
cord-032438-cpoalxyd	37	54	termed	term	VBN
cord-032438-cpoalxyd	37	55	mosaic	mosaic	JJ
cord-032438-cpoalxyd	37	56	effectiveness	effectiveness	NN
cord-032438-cpoalxyd	37	57	.	.	.
cord-032438-cpoalxyd	38	1	8	8	CD
cord-032438-cpoalxyd	39	1	If	if	IN
cord-032438-cpoalxyd	39	2	preferences	preference	NNS
cord-032438-cpoalxyd	39	3	are	be	VBP
cord-032438-cpoalxyd	39	4	measured	measure	VBN
cord-032438-cpoalxyd	39	5	,	,	,
cord-032438-cpoalxyd	39	6	effects	effect	NNS
cord-032438-cpoalxyd	39	7	stratified	stratify	VBN
cord-032438-cpoalxyd	39	8	by	by	IN
cord-032438-cpoalxyd	39	9	such	such	JJ
cord-032438-cpoalxyd	39	10	preferences	preference	NNS
cord-032438-cpoalxyd	39	11	can	can	MD
cord-032438-cpoalxyd	39	12	inform	inform	VB
cord-032438-cpoalxyd	39	13	tailoring	tailor	VBG
cord-032438-cpoalxyd	39	14	of	of	IN
cord-032438-cpoalxyd	39	15	services	service	NNS
cord-032438-cpoalxyd	39	16	to	to	IN
cord-032438-cpoalxyd	39	17	the	the	DT
cord-032438-cpoalxyd	39	18	individual	individual	NN
cord-032438-cpoalxyd	39	19	.	.	.
cord-032438-cpoalxyd	40	1	Overall	overall	RB
cord-032438-cpoalxyd	40	2	,	,	,
cord-032438-cpoalxyd	40	3	the	the	DT
cord-032438-cpoalxyd	40	4	results	result	NNS
cord-032438-cpoalxyd	40	5	from	from	IN
cord-032438-cpoalxyd	40	6	the	the	DT
cord-032438-cpoalxyd	40	7	DO	DO	NNP
cord-032438-cpoalxyd	40	8	-	-	HYPH
cord-032438-cpoalxyd	40	9	ART	art	NN
cord-032438-cpoalxyd	40	10	study	study	NN
cord-032438-cpoalxyd	40	11	extend	extend	VB
cord-032438-cpoalxyd	40	12	our	-PRON-	PRP$
cord-032438-cpoalxyd	40	13	public	public	JJ
cord-032438-cpoalxyd	40	14	health	health	NN
cord-032438-cpoalxyd	40	15	tool	tool	NN
cord-032438-cpoalxyd	40	16	kit	kit	NN
cord-032438-cpoalxyd	40	17	and	and	CC
cord-032438-cpoalxyd	40	18	has	have	VBZ
cord-032438-cpoalxyd	40	19	implications	implication	NNS
cord-032438-cpoalxyd	40	20	for	for	IN
cord-032438-cpoalxyd	40	21	management	management	NN
cord-032438-cpoalxyd	40	22	of	of	IN
cord-032438-cpoalxyd	40	23	adults	adult	NNS
cord-032438-cpoalxyd	40	24	with	with	IN
cord-032438-cpoalxyd	40	25	virological	virological	JJ
cord-032438-cpoalxyd	40	26	failure	failure	NN
cord-032438-cpoalxyd	40	27	who	who	WP
cord-032438-cpoalxyd	40	28	are	be	VBP
cord-032438-cpoalxyd	40	29	not	not	RB
cord-032438-cpoalxyd	40	30	eligible	eligible	JJ
cord-032438-cpoalxyd	40	31	for	for	IN
cord-032438-cpoalxyd	40	32	differentiated	differentiated	JJ
cord-032438-cpoalxyd	40	33	service	service	NN
cord-032438-cpoalxyd	40	34	delivery	delivery	NN
cord-032438-cpoalxyd	40	35	.	.	.
cord-032438-cpoalxyd	41	1	Further	further	JJ
cord-032438-cpoalxyd	41	2	research	research	NN
cord-032438-cpoalxyd	41	3	with	with	IN
cord-032438-cpoalxyd	41	4	longer	long	JJR
cord-032438-cpoalxyd	41	5	-	-	HYPH
cord-032438-cpoalxyd	41	6	term	term	NN
cord-032438-cpoalxyd	41	7	follow	follow	NN
cord-032438-cpoalxyd	41	8	-	-	HYPH
cord-032438-cpoalxyd	41	9	up	up	NN
cord-032438-cpoalxyd	41	10	is	be	VBZ
cord-032438-cpoalxyd	41	11	required	require	VBN
cord-032438-cpoalxyd	41	12	to	to	TO
cord-032438-cpoalxyd	41	13	measure	measure	VB
cord-032438-cpoalxyd	41	14	sustained	sustained	JJ
cord-032438-cpoalxyd	41	15	success	success	NN
cord-032438-cpoalxyd	41	16	over	over	IN
cord-032438-cpoalxyd	41	17	time	time	NN
cord-032438-cpoalxyd	41	18	and	and	CC
cord-032438-cpoalxyd	41	19	costeffectiveness	costeffectiveness	NN
cord-032438-cpoalxyd	41	20	to	to	TO
cord-032438-cpoalxyd	41	21	inform	inform	VB
cord-032438-cpoalxyd	41	22	policy	policy	NN
cord-032438-cpoalxyd	41	23	makers	maker	NNS
cord-032438-cpoalxyd	41	24	.	.	.
cord-032438-cpoalxyd	42	1	Furthermore	furthermore	RB
cord-032438-cpoalxyd	42	2	,	,	,
cord-032438-cpoalxyd	42	3	home	home	NN
cord-032438-cpoalxyd	42	4	-	-	HYPH
cord-032438-cpoalxyd	42	5	based	base	VBN
cord-032438-cpoalxyd	42	6	case	case	NN
cord-032438-cpoalxyd	42	7	management	management	NN
cord-032438-cpoalxyd	42	8	could	could	MD
cord-032438-cpoalxyd	42	9	be	be	VB
cord-032438-cpoalxyd	42	10	effective	effective	JJ
cord-032438-cpoalxyd	42	11	for	for	IN
cord-032438-cpoalxyd	42	12	adolescents	adolescent	NNS
cord-032438-cpoalxyd	42	13	in	in	IN
cord-032438-cpoalxyd	42	14	particular	particular	JJ
cord-032438-cpoalxyd	42	15	,	,	,
cord-032438-cpoalxyd	42	16	9	9	CD
cord-032438-cpoalxyd	42	17	but	but	CC
cord-032438-cpoalxyd	42	18	these	these	DT
cord-032438-cpoalxyd	42	19	patients	patient	NNS
cord-032438-cpoalxyd	42	20	were	be	VBD
cord-032438-cpoalxyd	42	21	not	not	RB
cord-032438-cpoalxyd	42	22	included	include	VBN
cord-032438-cpoalxyd	42	23	in	in	IN
cord-032438-cpoalxyd	42	24	the	the	DT
cord-032438-cpoalxyd	42	25	study	study	NN
cord-032438-cpoalxyd	42	26	and	and	CC
cord-032438-cpoalxyd	42	27	whether	whether	IN
cord-032438-cpoalxyd	42	28	community	community	NN
cord-032438-cpoalxyd	42	29	-	-	HYPH
cord-032438-cpoalxyd	42	30	based	base	VBN
cord-032438-cpoalxyd	42	31	ART	art	NN
cord-032438-cpoalxyd	42	32	initiation	initiation	NN
cord-032438-cpoalxyd	42	33	and	and	CC
cord-032438-cpoalxyd	42	34	resupply	resupply	NN
cord-032438-cpoalxyd	42	35	is	be	VBZ
cord-032438-cpoalxyd	42	36	safe	safe	JJ
cord-032438-cpoalxyd	42	37	and	and	CC
cord-032438-cpoalxyd	42	38	effective	effective	JJ
cord-032438-cpoalxyd	42	39	for	for	IN
cord-032438-cpoalxyd	42	40	this	this	DT
cord-032438-cpoalxyd	42	41	population	population	NN
cord-032438-cpoalxyd	42	42	is	be	VBZ
cord-032438-cpoalxyd	42	43	unknown	unknown	JJ
cord-032438-cpoalxyd	42	44	.	.	.
cord-032438-cpoalxyd	43	1	The	the	DT
cord-032438-cpoalxyd	43	2	DO	DO	NNP
cord-032438-cpoalxyd	43	3	-	-	HYPH
cord-032438-cpoalxyd	43	4	ART	art	NN
cord-032438-cpoalxyd	43	5	study	study	NN
cord-032438-cpoalxyd	43	6	adds	add	VBZ
cord-032438-cpoalxyd	43	7	further	further	RB
cord-032438-cpoalxyd	43	8	to	to	IN
cord-032438-cpoalxyd	43	9	the	the	DT
cord-032438-cpoalxyd	43	10	ongoing	ongoing	JJ
cord-032438-cpoalxyd	43	11	debate	debate	NN
cord-032438-cpoalxyd	43	12	and	and	CC
cord-032438-cpoalxyd	43	13	dialogue	dialogue	NN
cord-032438-cpoalxyd	43	14	on	on	IN
cord-032438-cpoalxyd	43	15	the	the	DT
cord-032438-cpoalxyd	43	16	optimal	optimal	JJ
cord-032438-cpoalxyd	43	17	package	package	NN
cord-032438-cpoalxyd	43	18	of	of	IN
cord-032438-cpoalxyd	43	19	care	care	NN
cord-032438-cpoalxyd	43	20	needed	need	VBN
cord-032438-cpoalxyd	43	21	to	to	TO
cord-032438-cpoalxyd	43	22	achieve	achieve	VB
cord-032438-cpoalxyd	43	23	the	the	DT
cord-032438-cpoalxyd	43	24	third	third	JJ
cord-032438-cpoalxyd	43	25	90	90	CD
cord-032438-cpoalxyd	43	26	(	(	-LRB-
cord-032438-cpoalxyd	43	27	virological	virological	JJ
cord-032438-cpoalxyd	43	28	suppression	suppression	NN
cord-032438-cpoalxyd	43	29	)	)	-RRB-
cord-032438-cpoalxyd	43	30	of	of	IN
cord-032438-cpoalxyd	43	31	the	the	DT
cord-032438-cpoalxyd	43	32	UNAIDS	UNAIDS	NNP
cord-032438-cpoalxyd	43	33	90	90	CD
cord-032438-cpoalxyd	43	34	-	-	HYPH
cord-032438-cpoalxyd	43	35	90	90	CD
cord-032438-cpoalxyd	43	36	-	-	SYM
cord-032438-cpoalxyd	43	37	90	90	CD
cord-032438-cpoalxyd	43	38	targets	target	NNS
cord-032438-cpoalxyd	43	39	for	for	IN
cord-032438-cpoalxyd	43	40	AIDS	AIDS	NNP
cord-032438-cpoalxyd	43	41	elimination	elimination	NN
cord-032438-cpoalxyd	43	42	by	by	IN
cord-032438-cpoalxyd	43	43	2030	2030	CD
cord-032438-cpoalxyd	43	44	.	.	.
cord-032438-cpoalxyd	44	1	10	10	CD
cord-032438-cpoalxyd	44	2	JBN	jbn	NN
cord-032438-cpoalxyd	44	3	is	be	VBZ
cord-032438-cpoalxyd	44	4	an	an	DT
cord-032438-cpoalxyd	44	5	infectious	infectious	JJ
cord-032438-cpoalxyd	44	6	diseases	disease	NNS
cord-032438-cpoalxyd	44	7	internist	internist	NN
cord-032438-cpoalxyd	44	8	and	and	CC
cord-032438-cpoalxyd	44	9	epidemiologist	epidemiologist	NN
cord-032438-cpoalxyd	44	10	supported	support	VBN
cord-032438-cpoalxyd	44	11	by	by	IN
cord-032438-cpoalxyd	44	12	the	the	DT
cord-032438-cpoalxyd	44	13	US	US	NNP
cord-032438-cpoalxyd	44	14	National	National	NNP
cord-032438-cpoalxyd	44	15	Institutes	Institutes	NNPS
cord-032438-cpoalxyd	44	16	of	of	IN
cord-032438-cpoalxyd	44	17	Health	Health	NNP
cord-032438-cpoalxyd	44	18	(	(	-LRB-
cord-032438-cpoalxyd	44	19	NIH)/National	NIH)/National	NNP
cord-032438-cpoalxyd	44	20	Institutes	Institutes	NNPS
cord-032438-cpoalxyd	44	21	of	of	IN
cord-032438-cpoalxyd	44	22	Allergy	Allergy	NNP
cord-032438-cpoalxyd	44	23	and	and	CC
cord-032438-cpoalxyd	44	24	Infectious	Infectious	NNP
cord-032438-cpoalxyd	44	25	Diseases	Diseases	NNPS
cord-032438-cpoalxyd	45	1	(	(	-LRB-
cord-032438-cpoalxyd	45	2	grant	grant	NN
cord-032438-cpoalxyd	45	3	number	number	NN
cord-032438-cpoalxyd	45	4	5U01AI069521	5u01ai069521	CD
cord-032438-cpoalxyd	45	5	;	;	:
cord-032438-cpoalxyd	45	6	Stellenbosch	Stellenbosch	NNP
cord-032438-cpoalxyd	45	7	University	University	NNP
cord-032438-cpoalxyd	45	8	Clinical	Clinical	NNP
cord-032438-cpoalxyd	45	9	Trial	Trial	NNP
cord-032438-cpoalxyd	45	10	Unit	Unit	NNP
cord-032438-cpoalxyd	45	11	of	of	IN
cord-032438-cpoalxyd	45	12	the	the	DT
cord-032438-cpoalxyd	45	13	AIDS	AIDS	NNP
cord-032438-cpoalxyd	45	14	Clinical	Clinical	NNP
cord-032438-cpoalxyd	45	15	Trial	Trial	NNP
cord-032438-cpoalxyd	45	16	Group	Group	NNP
cord-032438-cpoalxyd	45	17	)	)	-RRB-
cord-032438-cpoalxyd	45	18	as	as	RB
cord-032438-cpoalxyd	45	19	well	well	RB
cord-032438-cpoalxyd	45	20	as	as	IN
cord-032438-cpoalxyd	45	21	NIH	NIH	NNP
cord-032438-cpoalxyd	45	22	/	/	SYM
cord-032438-cpoalxyd	45	23	Fogarty	Fogarty	NNP
cord-032438-cpoalxyd	45	24	International	International	NNP
cord-032438-cpoalxyd	45	25	Center	Center	NNP
cord-032438-cpoalxyd	46	1	(	(	-LRB-
cord-032438-cpoalxyd	46	2	grant	grant	NN
cord-032438-cpoalxyd	46	3	numbers	number	NNS
cord-032438-cpoalxyd	46	4	1R25TW011217	1R25TW011217	NNP
cord-032438-cpoalxyd	46	5	-	-	HYPH
cord-032438-cpoalxyd	46	6	01	01	CD
cord-032438-cpoalxyd	46	7	;	;	:
cord-032438-cpoalxyd	46	8	African	African	NNP
cord-032438-cpoalxyd	46	9	Association	Association	NNP
cord-032438-cpoalxyd	46	10	for	for	IN
cord-032438-cpoalxyd	46	11	Health	Health	NNP
cord-032438-cpoalxyd	46	12	Professions	Professions	NNPS
cord-032438-cpoalxyd	46	13	Education	Education	NNP
cord-032438-cpoalxyd	46	14	and	and	CC
cord-032438-cpoalxyd	46	15	Research	Research	NNP
cord-032438-cpoalxyd	46	16	)	)	-RRB-
cord-032438-cpoalxyd	46	17	and	and	CC
cord-032438-cpoalxyd	46	18	1D43TW010937	1d43tw010937	CD
cord-032438-cpoalxyd	46	19	-	-	HYPH
cord-032438-cpoalxyd	46	20	01A1	01a1	CD
cord-032438-cpoalxyd	47	1	(	(	-LRB-
cord-032438-cpoalxyd	47	2	University	University	NNP
cord-032438-cpoalxyd	47	3	of	of	IN
cord-032438-cpoalxyd	47	4	Pittsburgh	Pittsburgh	NNP
cord-032438-cpoalxyd	47	5	HIV	HIV	NNP
cord-032438-cpoalxyd	47	6	Comorbidities	Comorbidities	NNP
cord-032438-cpoalxyd	47	7	Research	Research	NNP
cord-032438-cpoalxyd	47	8	Training	Training	NNP
cord-032438-cpoalxyd	47	9	Programme	Programme	NNP
cord-032438-cpoalxyd	47	10	in	in	IN
cord-032438-cpoalxyd	47	11	South	South	NNP
cord-032438-cpoalxyd	47	12	Africa	Africa	NNP
cord-032438-cpoalxyd	47	13	)	)	-RRB-
cord-032438-cpoalxyd	47	14	,	,	,
cord-032438-cpoalxyd	47	15	and	and	CC
cord-032438-cpoalxyd	47	16	is	be	VBZ
cord-032438-cpoalxyd	47	17	co	co	JJ
cord-032438-cpoalxyd	47	18	-	-	JJ
cord-032438-cpoalxyd	47	19	principal	principal	JJ
cord-032438-cpoalxyd	47	20	investigator	investigator	NN
cord-032438-cpoalxyd	47	21	of	of	IN
cord-032438-cpoalxyd	47	22	TOGETHER	together	RB
cord-032438-cpoalxyd	47	23	,	,	,
cord-032438-cpoalxyd	47	24	an	an	DT
cord-032438-cpoalxyd	47	25	adaptive	adaptive	JJ
cord-032438-cpoalxyd	47	26	randomised	randomised	JJ
cord-032438-cpoalxyd	47	27	clinical	clinical	JJ
cord-032438-cpoalxyd	47	28	trial	trial	NN
cord-032438-cpoalxyd	47	29	of	of	IN
cord-032438-cpoalxyd	47	30	novel	novel	JJ
cord-032438-cpoalxyd	47	31	agents	agent	NNS
cord-032438-cpoalxyd	47	32	for	for	IN
cord-032438-cpoalxyd	47	33	treatment	treatment	NN
cord-032438-cpoalxyd	47	34	of	of	IN
cord-032438-cpoalxyd	47	35	patients	patient	NNS
cord-032438-cpoalxyd	47	36	who	who	WP
cord-032438-cpoalxyd	47	37	are	be	VBP
cord-032438-cpoalxyd	47	38	high	high	JJ
cord-032438-cpoalxyd	47	39	-	-	HYPH
cord-032438-cpoalxyd	47	40	risk	risk	NN
cord-032438-cpoalxyd	47	41	outpatients	outpatient	NNS
cord-032438-cpoalxyd	47	42	with	with	IN
cord-032438-cpoalxyd	47	43	COVID-19	COVID-19	NNP
cord-032438-cpoalxyd	47	44	in	in	IN
cord-032438-cpoalxyd	47	45	South	South	NNP
cord-032438-cpoalxyd	47	46	Africa	Africa	NNP
cord-032438-cpoalxyd	47	47	supported	support	VBN
cord-032438-cpoalxyd	47	48	by	by	IN
cord-032438-cpoalxyd	47	49	the	the	DT
cord-032438-cpoalxyd	47	50	Bill	Bill	NNP
cord-032438-cpoalxyd	47	51	&	&	CC
cord-032438-cpoalxyd	47	52	Melinda	Melinda	NNP
cord-032438-cpoalxyd	47	53	Gates	Gates	NNP
cord-032438-cpoalxyd	47	54	Foundation	Foundation	NNP
cord-032438-cpoalxyd	47	55	.	.	.
cord-032438-cpoalxyd	48	1	AZ	AZ	NNP
cord-032438-cpoalxyd	48	2	is	be	VBZ
cord-032438-cpoalxyd	48	3	a	a	DT
cord-032438-cpoalxyd	48	4	co	co	JJ
cord-032438-cpoalxyd	48	5	-	-	JJ
cord-032438-cpoalxyd	48	6	principal	principal	JJ
cord-032438-cpoalxyd	48	7	investigator	investigator	NN
cord-032438-cpoalxyd	48	8	of	of	IN
cord-032438-cpoalxyd	48	9	the	the	DT
cord-032438-cpoalxyd	48	10	Pan	Pan	NNP
cord-032438-cpoalxyd	48	11	-	-	NNP
cord-032438-cpoalxyd	48	12	African	African	NNP
cord-032438-cpoalxyd	48	13	Network	Network	NNP
cord-032438-cpoalxyd	48	14	on	on	IN
cord-032438-cpoalxyd	48	15	Emerging	Emerging	NNP
cord-032438-cpoalxyd	48	16	and	and	CC
cord-032438-cpoalxyd	48	17	Re	Re	NNP
cord-032438-cpoalxyd	48	18	-	-	NN
cord-032438-cpoalxyd	48	19	Emerging	Emerging	NNP
cord-032438-cpoalxyd	48	20	Infections	infection	NNS
cord-032438-cpoalxyd	48	21	funded	fund	VBN
cord-032438-cpoalxyd	48	22	by	by	IN
cord-032438-cpoalxyd	48	23	the	the	DT
cord-032438-cpoalxyd	48	24	European	european	JJ
cord-032438-cpoalxyd	48	25	and	and	CC
cord-032438-cpoalxyd	48	26	Developing	Developing	NNP
cord-032438-cpoalxyd	48	27	Countries	Countries	NNPS
cord-032438-cpoalxyd	48	28	Clinical	Clinical	NNP
cord-032438-cpoalxyd	48	29	Trials	Trials	NNPS
cord-032438-cpoalxyd	48	30	Partnership	Partnership	NNP
cord-032438-cpoalxyd	48	31	and	and	CC
cord-032438-cpoalxyd	48	32	is	be	VBZ
cord-032438-cpoalxyd	48	33	in	in	IN
cord-032438-cpoalxyd	48	34	receipt	receipt	NN
cord-032438-cpoalxyd	48	35	of	of	IN
cord-032438-cpoalxyd	48	36	an	an	DT
cord-032438-cpoalxyd	48	37	NIH	NIH	NNP
cord-032438-cpoalxyd	48	38	Research	Research	NNP
cord-032438-cpoalxyd	48	39	Senior	Senior	NNP
cord-032438-cpoalxyd	48	40	Investigator	Investigator	NNP
cord-032438-cpoalxyd	48	41	award	award	NN
cord-032438-cpoalxyd	48	42	.	.	.
cord-032438-cpoalxyd	49	1	We	-PRON-	PRP
cord-032438-cpoalxyd	49	2	acknowledge	acknowledge	VBP
cord-032438-cpoalxyd	49	3	the	the	DT
cord-032438-cpoalxyd	49	4	critical	critical	JJ
cord-032438-cpoalxyd	49	5	UNAIDS	UNAIDS	NNP
cord-032438-cpoalxyd	49	6	.	.	.
cord-032438-cpoalxyd	50	1	Global	Global	NNP
cord-032438-cpoalxyd	50	2	AIDS	AIDS	NNP
cord-032438-cpoalxyd	50	3	Update	update	NN
cord-032438-cpoalxyd	50	4	.	.	.
cord-032438-cpoalxyd	51	1	2020	2020	CD
cord-032438-cpoalxyd	51	2	Community	community	NN
cord-032438-cpoalxyd	51	3	-	-	HYPH
cord-032438-cpoalxyd	51	4	based	base	VBN
cord-032438-cpoalxyd	51	5	antiretroviral	antiretroviral	JJ
cord-032438-cpoalxyd	51	6	therapy	therapy	NN
cord-032438-cpoalxyd	51	7	versus	versus	IN
cord-032438-cpoalxyd	51	8	standard	standard	JJ
cord-032438-cpoalxyd	51	9	clinic	clinic	NN
cord-032438-cpoalxyd	51	10	-	-	HYPH
cord-032438-cpoalxyd	51	11	based	base	VBN
cord-032438-cpoalxyd	51	12	services	service	NNS
cord-032438-cpoalxyd	51	13	for	for	IN
cord-032438-cpoalxyd	51	14	HIV	HIV	NNP
cord-032438-cpoalxyd	51	15	in	in	IN
cord-032438-cpoalxyd	51	16	South	South	NNP
cord-032438-cpoalxyd	51	17	Africa	Africa	NNP
cord-032438-cpoalxyd	51	18	and	and	CC
cord-032438-cpoalxyd	51	19	Uganda	Uganda	NNP
cord-032438-cpoalxyd	51	20	(	(	-LRB-
cord-032438-cpoalxyd	51	21	DO	DO	NNP
cord-032438-cpoalxyd	51	22	ART	art	NN
cord-032438-cpoalxyd	51	23	)	)	-RRB-
cord-032438-cpoalxyd	52	1	:	:	:
cord-032438-cpoalxyd	52	2	a	a	DT
cord-032438-cpoalxyd	52	3	randomised	randomised	JJ
cord-032438-cpoalxyd	52	4	trial	trial	NN
cord-032438-cpoalxyd	52	5	Community	community	NN
cord-032438-cpoalxyd	52	6	-	-	HYPH
cord-032438-cpoalxyd	52	7	based	base	VBN
cord-032438-cpoalxyd	52	8	interventions	intervention	NNS
cord-032438-cpoalxyd	52	9	to	to	TO
cord-032438-cpoalxyd	52	10	improve	improve	VB
cord-032438-cpoalxyd	52	11	and	and	CC
cord-032438-cpoalxyd	52	12	sustain	sustain	VB
cord-032438-cpoalxyd	52	13	antiretroviral	antiretroviral	JJ
cord-032438-cpoalxyd	52	14	therapy	therapy	NN
cord-032438-cpoalxyd	52	15	adherence	adherence	NN
cord-032438-cpoalxyd	52	16	,	,	,
cord-032438-cpoalxyd	52	17	retention	retention	NN
cord-032438-cpoalxyd	52	18	in	in	IN
cord-032438-cpoalxyd	52	19	HIV	HIV	NNP
cord-032438-cpoalxyd	52	20	care	care	NN
cord-032438-cpoalxyd	52	21	and	and	CC
cord-032438-cpoalxyd	52	22	clinical	clinical	JJ
cord-032438-cpoalxyd	52	23	outcomes	outcome	NNS
cord-032438-cpoalxyd	52	24	in	in	IN
cord-032438-cpoalxyd	52	25	low	low	JJ
cord-032438-cpoalxyd	52	26	-	-	HYPH
cord-032438-cpoalxyd	52	27	and	and	CC
cord-032438-cpoalxyd	52	28	middle	middle	JJ
cord-032438-cpoalxyd	52	29	-	-	HYPH
cord-032438-cpoalxyd	52	30	income	income	NN
cord-032438-cpoalxyd	52	31	countries	country	NNS
cord-032438-cpoalxyd	52	32	for	for	IN
cord-032438-cpoalxyd	52	33	achieving	achieve	VBG
cord-032438-cpoalxyd	52	34	the	the	DT
cord-032438-cpoalxyd	52	35	UNAIDS	UNAIDS	NNP
cord-032438-cpoalxyd	52	36	90	90	CD
cord-032438-cpoalxyd	52	37	-	-	HYPH
cord-032438-cpoalxyd	52	38	90	90	CD
cord-032438-cpoalxyd	52	39	-	-	SYM
cord-032438-cpoalxyd	52	40	90	90	CD
cord-032438-cpoalxyd	52	41	targets	target	NNS
cord-032438-cpoalxyd	52	42	The	the	DT
cord-032438-cpoalxyd	52	43	effectiveness	effectiveness	NN
cord-032438-cpoalxyd	52	44	and	and	CC
cord-032438-cpoalxyd	52	45	cost	cost	NN
cord-032438-cpoalxyd	52	46	-	-	HYPH
cord-032438-cpoalxyd	52	47	effectiveness	effectiveness	NN
cord-032438-cpoalxyd	52	48	of	of	IN
cord-032438-cpoalxyd	52	49	community	community	NN
cord-032438-cpoalxyd	52	50	-	-	HYPH
cord-032438-cpoalxyd	52	51	based	base	VBN
cord-032438-cpoalxyd	52	52	support	support	NN
cord-032438-cpoalxyd	52	53	for	for	IN
cord-032438-cpoalxyd	52	54	adolescents	adolescent	NNS
cord-032438-cpoalxyd	52	55	receiving	receive	VBG
cord-032438-cpoalxyd	52	56	antiretroviral	antiretroviral	JJ
cord-032438-cpoalxyd	52	57	treatment	treatment	NN
cord-032438-cpoalxyd	52	58	:	:	:
cord-032438-cpoalxyd	52	59	an	an	DT
cord-032438-cpoalxyd	52	60	operational	operational	JJ
cord-032438-cpoalxyd	52	61	research	research	NN
cord-032438-cpoalxyd	52	62	study	study	NN
cord-032438-cpoalxyd	52	63	in	in	IN
cord-032438-cpoalxyd	52	64	South	South	NNP
cord-032438-cpoalxyd	52	65	Africa	Africa	NNP
cord-032438-cpoalxyd	52	66	Effect	Effect	NNP
cord-032438-cpoalxyd	52	67	of	of	IN
cord-032438-cpoalxyd	52	68	offering	offer	VBG
cord-032438-cpoalxyd	52	69	same	same	JJ
cord-032438-cpoalxyd	52	70	-	-	HYPH
cord-032438-cpoalxyd	52	71	day	day	NN
cord-032438-cpoalxyd	52	72	art	art	NN
cord-032438-cpoalxyd	52	73	vs	vs	IN
cord-032438-cpoalxyd	52	74	usual	usual	JJ
cord-032438-cpoalxyd	52	75	health	health	NN
cord-032438-cpoalxyd	52	76	facility	facility	NN
cord-032438-cpoalxyd	52	77	referral	referral	NN
cord-032438-cpoalxyd	52	78	during	during	IN
cord-032438-cpoalxyd	52	79	home	home	NN
cord-032438-cpoalxyd	52	80	-	-	HYPH
cord-032438-cpoalxyd	52	81	based	base	VBN
cord-032438-cpoalxyd	52	82	hiv	hiv	NNP
cord-032438-cpoalxyd	52	83	testing	test	VBG
cord-032438-cpoalxyd	52	84	on	on	IN
cord-032438-cpoalxyd	52	85	linkage	linkage	NN
cord-032438-cpoalxyd	52	86	to	to	TO
cord-032438-cpoalxyd	52	87	care	care	VB
cord-032438-cpoalxyd	52	88	and	and	CC
cord-032438-cpoalxyd	52	89	viral	viral	JJ
cord-032438-cpoalxyd	52	90	suppression	suppression	NN
cord-032438-cpoalxyd	52	91	among	among	IN
cord-032438-cpoalxyd	52	92	adults	adult	NNS
cord-032438-cpoalxyd	52	93	with	with	IN
cord-032438-cpoalxyd	52	94	HIV	HIV	NNP
cord-032438-cpoalxyd	52	95	in	in	IN
cord-032438-cpoalxyd	52	96	Lesotho	Lesotho	NNP
cord-032438-cpoalxyd	52	97	:	:	:
cord-032438-cpoalxyd	52	98	the	the	DT
cord-032438-cpoalxyd	52	99	CASCADE	CASCADE	NNP
cord-032438-cpoalxyd	52	100	randomized	randomize	VBD
cord-032438-cpoalxyd	52	101	clinical	clinical	JJ
cord-032438-cpoalxyd	52	102	trial	trial	NN
cord-032438-cpoalxyd	52	103	Twelve	twelve	CD
cord-032438-cpoalxyd	52	104	-	-	HYPH
cord-032438-cpoalxyd	52	105	month	month	NN
cord-032438-cpoalxyd	52	106	outcomes	outcome	NNS
cord-032438-cpoalxyd	52	107	of	of	IN
cord-032438-cpoalxyd	52	108	communitybased	communitybased	JJ
cord-032438-cpoalxyd	52	109	differentiated	differentiated	JJ
cord-032438-cpoalxyd	52	110	models	model	NNS
cord-032438-cpoalxyd	52	111	of	of	IN
cord-032438-cpoalxyd	52	112	multi	multi	JJ
cord-032438-cpoalxyd	52	113	-	-	JJ
cord-032438-cpoalxyd	52	114	month	month	NN
cord-032438-cpoalxyd	52	115	dispensing	dispensing	NN
cord-032438-cpoalxyd	52	116	of	of	IN
cord-032438-cpoalxyd	52	117	antiretroviral	antiretroviral	JJ
cord-032438-cpoalxyd	52	118	treatment	treatment	NN
cord-032438-cpoalxyd	52	119	among	among	IN
cord-032438-cpoalxyd	52	120	stable	stable	JJ
cord-032438-cpoalxyd	52	121	HIV	HIV	NNP
cord-032438-cpoalxyd	52	122	-	-	HYPH
cord-032438-cpoalxyd	52	123	infected	infect	VBN
cord-032438-cpoalxyd	52	124	adults	adult	NNS
cord-032438-cpoalxyd	52	125	in	in	IN
cord-032438-cpoalxyd	52	126	Lesotho	Lesotho	NNP
cord-032438-cpoalxyd	52	127	:	:	:
cord-032438-cpoalxyd	52	128	a	a	DT
cord-032438-cpoalxyd	52	129	cluster	cluster	NN
cord-032438-cpoalxyd	52	130	randomized	randomize	VBN
cord-032438-cpoalxyd	52	131	non	non	JJ
cord-032438-cpoalxyd	52	132	-	-	JJ
cord-032438-cpoalxyd	52	133	inferiority	inferiority	JJ
cord-032438-cpoalxyd	52	134	trial	trial	NN
cord-032438-cpoalxyd	52	135	Economic	economic	JJ
cord-032438-cpoalxyd	52	136	evaluation	evaluation	NN
cord-032438-cpoalxyd	52	137	of	of	IN
cord-032438-cpoalxyd	52	138	differentiated	differentiated	JJ
cord-032438-cpoalxyd	52	139	service	service	NN
cord-032438-cpoalxyd	52	140	delivery	delivery	NN
cord-032438-cpoalxyd	52	141	models	model	NNS
cord-032438-cpoalxyd	52	142	for	for	IN
cord-032438-cpoalxyd	52	143	ART	art	NN
cord-032438-cpoalxyd	52	144	service	service	NN
cord-032438-cpoalxyd	52	145	delivery	delivery	NN
cord-032438-cpoalxyd	52	146	in	in	IN
cord-032438-cpoalxyd	52	147	Lesotho	Lesotho	NNP
cord-032438-cpoalxyd	52	148	:	:	:
cord-032438-cpoalxyd	52	149	cost	cost	NN
cord-032438-cpoalxyd	52	150	to	to	IN
cord-032438-cpoalxyd	52	151	provider	provider	NN
cord-032438-cpoalxyd	52	152	and	and	CC
cord-032438-cpoalxyd	52	153	cost	cost	VB
cord-032438-cpoalxyd	52	154	to	to	TO
cord-032438-cpoalxyd	52	155	patient	patient	VB
cord-032438-cpoalxyd	52	156	Mosaic	Mosaic	NNP
cord-032438-cpoalxyd	52	157	effectiveness	effectiveness	NN
cord-032438-cpoalxyd	52	158	:	:	:
cord-032438-cpoalxyd	52	159	measuring	measure	VBG
cord-032438-cpoalxyd	52	160	the	the	DT
cord-032438-cpoalxyd	52	161	impact	impact	NN
cord-032438-cpoalxyd	52	162	of	of	IN
cord-032438-cpoalxyd	52	163	novel	novel	JJ
cord-032438-cpoalxyd	52	164	PrEP	prep	NN
cord-032438-cpoalxyd	52	165	methods	method	NNS
cord-032438-cpoalxyd	52	166	Interventions	intervention	NNS
cord-032438-cpoalxyd	52	167	to	to	TO
cord-032438-cpoalxyd	52	168	improve	improve	VB
cord-032438-cpoalxyd	52	169	antiretroviral	antiretroviral	JJ
cord-032438-cpoalxyd	52	170	therapy	therapy	NN
cord-032438-cpoalxyd	52	171	adherence	adherence	NN
cord-032438-cpoalxyd	52	172	among	among	IN
cord-032438-cpoalxyd	52	173	adolescents	adolescent	NNS
cord-032438-cpoalxyd	52	174	and	and	CC
cord-032438-cpoalxyd	52	175	youth	youth	NN
cord-032438-cpoalxyd	52	176	in	in	IN
cord-032438-cpoalxyd	52	177	low	low	JJ
cord-032438-cpoalxyd	52	178	-	-	:
cord-032438-cpoalxyd	52	179	and	and	CC
cord-032438-cpoalxyd	52	180	middleincome	middleincome	NNP
cord-032438-cpoalxyd	52	181	countries	country	NNS
cord-032438-cpoalxyd	52	182	:	:	:
cord-032438-cpoalxyd	52	183	a	a	DT
cord-032438-cpoalxyd	52	184	systematic	systematic	JJ
cord-032438-cpoalxyd	52	185	review	review	NN
cord-032438-cpoalxyd	52	186	Fast	Fast	NNP
cord-032438-cpoalxyd	52	187	-	-	HYPH
cord-032438-cpoalxyd	52	188	Track	Track	NNP
cord-032438-cpoalxyd	52	189	-	-	HYPH
cord-032438-cpoalxyd	52	190	Ending	end	VBG
cord-032438-cpoalxyd	52	191	the	the	DT
cord-032438-cpoalxyd	52	192	AIDS	AIDS	NNP
cord-032438-cpoalxyd	52	193	epidemic	epidemic	NN
cord-032438-cpoalxyd	52	194	by	by	IN
cord-032438-cpoalxyd	52	195	2030	2030	CD